收藏切换
Discussion on “quality control symmetry” (QC-Symmetry) of drugs and pharmaceutical excipients in Chinese patent medicine
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(4) : 1385 - 1393
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(4): 1385-1393
Discussion on “quality control symmetry” (QC-Symmetry) of drugs and pharmaceutical excipients in Chinese patent medicine
Full
XU Yang1,2, ZHOU Weijun3, ZHENG Weiran4, YANG Jian1,2, WANG Yixin1,2, LIU Tao3
Affiliations
    1 College of Pharmacy, Chengdu University, Chengdu 610100, China;
    2 Zhanglan College, Chengdu University, Chengdu 610100, China;
    3 College of Food and Bioengineering, Chengdu University, Chengdu 610100, China;
    4 Heilongjiang Agricultural Engineering Vocational College, Harbin 150025, China
doi: 10.7501/j.issn.0253-2670.2025.04.026
Outline
收藏切换
Pharmaceutical excipients are an indispensable part of preparation prescriptions. Under the background of continuous improvement of drug quality standards, relatively few studies focus on the quality changes of pharmaceutical excipients during and after drug formation and their effects on the overall safety and efficacy of drugs, especially in the research of Chinese patent medicines. Based on the quality standard of traditional Chinese medicine, insufficient attention has been paid to the quality control of pharmaceutical excipients, in this paper, the concepts of “quality control symmetry (QC-Symmetry)” and “quality control asymmetry (QC-Asymmetry)” between drugs and pharmaceutical excipients are proposed, and the QC-Asymmetry problems of Chinese patent medicines and pharmaceutical excipients are discussed. It provides a reference for the quality evaluation of pharmaceutical excipients to be included in the quality and process evaluation process of Chinese patent medicines, aiming to achieve symmetry and adaptation in quality and process control, thereby improving the quality control strategy of Chinese patent medicine and other pharmaceutical preparations.
pharmaceutical excipients  /  quality control symmetry  /  Chinese patent medicine  /  quality standards  /  prolonged with the drug  /  production process  /  period of validity
徐杨, 周伟俊, 郑伟然, 杨键, 王艺欣, 刘涛. 中成药中药物和药用辅料“质控对称”(QC-Symmetry)的探讨. 中草药, 2025 , 56 (4) : 1385 -1393 . DOI: 10.7501/j.issn.0253-2670.2025.04.026
XU Yang, ZHOU Weijun, ZHENG Weiran, YANG Jian, WANG Yixin, LIU Tao. Discussion on “quality control symmetry” (QC-Symmetry) of drugs and pharmaceutical excipients in Chinese patent medicine[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (4) : 1385 -1393 . DOI: 10.7501/j.issn.0253-2670.2025.04.026
Year 2025 volume 56 Issue 4
35
6
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.04.026
  • Receive Date:2024-10-15
  • Online Date:2026-11-13
Article Data
Affiliations
History
  • Received:2024-10-15
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.04.026
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT